Company
Boehringer Ingelheim
Boehringer Ingelheim International GmbH
Private · Ingelheim am Rhein, Germany · Last verified Aug 15, 2024
Family-owned pharma co-developing survodutide with Zealand Pharma for NASH and obesity.
Company profile
- Legal name
- Boehringer Ingelheim International GmbH
- Status
- private
- Headquarters
- Ingelheim am Rhein, Germany
- Website
- www.boehringer-ingelheim.com
Active assets
| Asset | Stage | Indications |
|---|---|---|
| Survodutide | Phase 2 | — |
Trial roll-up
View all →| Registry ID | Phase | Title | Status |
|---|---|---|---|
| NCT05649174 | Phase 2 | A Study to Evaluate Survodutide in Participants With Non-alcoholic Steatohepatitis (NASH) | Active, not recruiting |
Deals
View all →| Parties | Type | Headline value | Announced |
|---|---|---|---|
| Boehringer Ingelheim International GmbH / Zealand Pharma A/S | partnership | Up to $500 million (contingent) | Jun 15, 2011 |